Open AccessANALYSIS OF TUBERCULOSIS TREATMENT SUITABILITY AND THE DRUG SUPERVISOR’S ROLE IN A COMMUNITY HEALTH CENTER IN PADEMANGAN SUBDISTRICT, NORTH JAKARTA
Author(s) -
Febriony Citra,
Purwantyastuti,
Meanaldi Rasmin,
Vivian Soetikno
Publication year - 2019
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2019.v11s1.030
Subject(s) - medicine , tuberculosis , sputum , drug , intervention (counseling) , community health center , directly observed therapy , family medicine , pharmacology , nursing , pathology
Objective: Appropriate tuberculosis (TB) treatment guidelines are one of the many factors that influence the success of TB treatment. The patient’sdrug supervisor is a functional role that is part of the directly observed treatment short course, a program to support the success of TB treatment.The aim of this study was to analyze the TB treatment suitability in a community health center and the benefit of treatment compliance supervisionby the patient’s designated drug supervisor.Methods: We conducted a cross-sectional study in the Community Health Center of Pademangan subdistrict, North Jakarta, involving 205 subjects toanalyze appropriate fixed-dose combination (FDC) anti-TB drug administration and an experimental study involving 23 control group TB patients and23 intervention group TB patients to assess the benefit of supervision by each patient’s drug supervisor.Results: The association of FDC anti-TB drug side effects with the success of TB treatment was not statistically significant (p=0.173). There wasan increase in drug supervisor knowledge of 8.6% in the intervention group and 13% in the control group. There was no statistically significantassociation between the knowledge of the drug supervisor and the 2nd month (p=0.575) and the 6th month of sputum treatment.Conclusion: Minor side effects of FDC anti-TB drug did not affect the success of TB treatment; therefore, treatment was continued if these adverseevents occurred. There were no correlations between the drug supervisor knowledge level with medication compliance or with sputum conversion(months 2 and 6).